Absorption and tolerability of aqueous chlorhexidine gluconate used for skin antisepsis prior to catheter insertion in preterm neonates

Journal of Perinatology

Volumn 33, Issue 10, 2013, Pages 768-771

  Chapman, A K ^a   Aucott, S W ^a   Gilmore, M M ^a   Advani, S ^a   Clarke, W ^a   Milstone, A M ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Chlorhexidine gluconate; Drug safety; Drug toxicity; Neonates; Prematurity

Indexed keywords

CHLORHEXIDINE GLUCONATE;

ANTISEPSIS; AQUEOUS SOLUTION; ARTICLE; BACTEREMIA; BIRTH WEIGHT; CLINICAL ARTICLE; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EXPOSURE; DRUG TOLERABILITY; ERYTHEMA; FEMALE; GESTATIONAL AGE; GROUP B STREPTOCOCCAL INFECTION; HUMAN; HYPERTRANSAMINASEMIA; INFANT; LIMIT OF QUANTITATION; MALE; NEWBORN; PERIPHERALLY INSERTED CENTRAL VENOUS CATHETER; PILOT STUDY; PREMATURITY; SIDE EFFECT; SKIN IRRITATION; SKIN TOXICITY; VEIN CATHETERIZATION;

ABSORPTION; ANTI-INFECTIVE AGENTS, LOCAL; ANTISEPSIS; CATHETERIZATION, PERIPHERAL; CHLORHEXIDINE; CHROMATOGRAPHY, LIQUID; FEMALE; HUMANS; INFANT CARE; INFANT, NEWBORN; INFANT, PREMATURE; MALE; PILOT PROJECTS; SKIN ABSORPTION; TANDEM MASS SPECTROMETRY;

EID: 84885022738     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/jp.2013.61     Document Type: Article

References (26)

1. Milstone AM, Passaretti CL, Perl TM. Chlorhexidine: Expanding the armamentarium for infection control and prevention. Clin Infect Dis 2008; 46(2): 274-281
2. O'Grady NP, Alexander M, Dellinger EP, Gerberding JL, Heard SO, Maki DG et al. Guidelines for the prevention of intravascular catheter-related infections. The Hospital Infection Control Practices Advisory Committee, Center for Disese Control and Prevention. Pediatrics 2002; 110(5): E51
3. Tamma PD, Aucott SW, Milstone AM. Chlorhexidine use in the neonatal intensive care unit: Results from a national survey. Infect Control Hosp Epidemiol 2010; 31(8): 846-849
4. U.S. Food and Drug Administration MedWatch (Internet). Silver Spring, MD, USA. http://www.fda.gov/Safety/MedWatch/SafetyInformation/Safety-Related- DrugLabelingChanges/ucm307387.htm. (U.S. Food and Drug Administration; 2012 (updated 12 June 2012; cited 27 November 2012)).
5. Aggett PJ, Cooper LV, Ellis SH, McAinsh J. Percutaneous absorption of chlorhexidine in neonatal cord care. Arch Dis Child 1981; 56(11): 878-880
6. Cowen J, Ellis SH, McAinsh J. Absorption of chlorhexidine from the intact skin of newborn infants. Arch Dis Child 1979; 54(5): 379-383
7. Garland JS, Alex CP, Uhing MR, Peterside IE, Rentz A, Harris MC. Pilot trial to compare tolerance of chlorhexidine gluconate to povidone-iodine antisepsis for central venous catheter placement in neonates. J Perinatol 2009; 29(12): 808-813
8. Johnsson J, Seeberg S, Kjellmer I. Blood concentrations of chlorhexidine in neonates undergoing routine cord care with 4% chlorhexidine gluconate solution. Acta Paediatr Scand 1987; 76(4): 675-676
9. Mullany LC, Khatry SK, Sherchand JB, Leclerq SC, Darmstadt GL, Katz J et al. A randomized controlled trial of the impact of chlorhexidine skin cleansing on bacterial colonization of hospital-born infants in Nepal. Pediatr Infect Dis J 2008; 27(6): 505-511
10. O'Brien CABJ, Speck WT, Carr H. Effect of bathing with a 4 per cent chlorhexidine gluconate solution on neonatal bacterial colonization. J Hosp Infect 1984; 5(suppl 1): 141
11. O'Neill JHM, Challop R, Driscoll J, Speck W, Sprunt K. Percutaneous absorption potential of chlorhexidine in neonates. Curr Ther Res 1982; 31(3): 485-489
12. Mullany LC, Darmstadt GL, Tielsch JM. Safety and impact of chlorhexidine antisepsis interventions for improving neonatal health in developing countries. Pediatr Infect Dis J 2006; 25(8): 665-675
13. Chapman AK, Aucott SW, Milstone AM. Safety of chlorhexidine gluconate used for skin antisepsis in the preterm infant. J Perinatol 2012; 32(1): 4-9
14. Milstone ABP, Aucott S, Bearer CF, Tang N. Chlorhexidine reduces L1-mediated neurite outgrowth. Annual Meeting of the Pediatric Academic Society Denver, 2011
15. Davies GE, Francis J, Martin AR, Rose FL, Swain G. 1:6-Di-4'- chlorophenyldiguanidohexane (hibitane); laboratory investigation of a new antibacterial agent of high potency. Br J Pharmacol Chemother 1954; 9(2): 192-196
16. Sebben JE. Surgical antiseptics. J Am Acad Dermatol 1983; 9(5): 759-765
17. Greaves SJ, Ferry DG, McQueen EG, Malcolm DS, Buckfield PM. Serial hexachlorophene blood levels in the premature infant. N Z Med J 1975; 81(537): 334-336
18. Kalia YN, Nonato LB, Lund CH, Guy RH. Development of skin barrier function in premature infants. J Invest Dermatol 1998; 111(2): 320-326
19. Barker N, Hadgraft J, Rutter N. Skin permeability in the newborn. J Invest Dermatol 1987; 88(4): 409-411
20. Reynolds PR, Banerjee S, Meek JH. Alcohol burns in extremely low birthweight infants: Still occurring. Arch Dis Child Fetal Neonatal Ed 2005; 90(1): F10
21. Watkins AM, Keogh EJ. Alcohol burns in the neonate. J Paediatr Child Health 1992; 28(4): 306-308
22. Bringue Espuny X, Soria X, Sole E, Garcia J, Marco JJ, Ortega J et al. Chlorhexidinemethanol burns in two extreme preterm newborns. Pediatr Dermatol 2010; 27(6): 676-678
23. Mannan K, Chow P, Lissauer T, Godambe S. Mistaken identity of skin cleansing solution leading to extensive chemical burns in an extremely preterm infant. Acta Paediatr 2007; 96(10): 1536-1537
24. Andersen C, Hart J, Vemgal P, Harrison C. Prospective evaluation of a multi-factorial prevention strategy on the impact of nosocomial infection in very-low-birthweight infants. J Hosp Infect 2005; 61(2): 162-167
25. Lashkari HP, Chow P, Godambe S. Aqueous 2% chlorhexidine-induced chemical burns in an extremely premature infant. Arch Dis Child Fetal Neonatal Ed 2012; 97(1): F64
26. Arifeen SE, Mullany LC, Shah R, Mannan I, Rahman SM, Talukder MR et al. The effect of cord cleansing with chlorhexidine on neonatal mortality in rural Bangladesh: A community-based, cluster-randomised trial. Lancet 2012; 379(9820): 1022-1028